|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/225 | |
| A61K 9/20 | |||
| A61K 31/197 |
| (11) | Number of the document | 1811986 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05826200.7 |
| Date of filing the European patent application | 2005-11-03 | |
| (97) | Date of publication of the European application | 2007-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/040127 |
| Date | 2005-11-03 |
| (87) | Number | WO 2006/050514 |
| Date | 2006-05-11 |
| (30) | Number | Date | Country code |
| 625737 P | 2004-11-04 | US |
| (72) |
CUNDY, Kenneth, C., US
SASTRY, Srikonda, US
LEUNG, Manshiu, US
KADRI, Balaji, V., US
STACH, Paul, E., US
|
| (73) |
XenoPort, Inc.,
3410 Central Expressway, Santa Clara, CA 95051,
US
|
| (54) | GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS |
| GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS |